drugset / Trial / NCT03917797
Mesenchymal Stromal Cells (MSC´s) in Renal Lupus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase II Clinical Trial to Assess the dose-response and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (MSCs) in Severe Renal Systemic Lupus Erythematosus (SLE).
Timeline
- Start
- 2019-04-02
- Primary completion
- 2024-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesenchymal stem cell | Cell therapy | — | Intravenous |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Methylprednisolone | Other / unclassified | — | — |
| Background | Mycophenolate Sodium | Unknown | — | — |
| Background | Prednisone | Other / unclassified | — | — |